ACORN BIOVENTURES, L.P. - 27 Mar 2026 SCHEDULE 13G Report for OnKure Therapeutics, Inc. Common Stock, $0.0001 Par Value (RPHM)

Filing Manager
ACORN BIOVENTURES, L.P.
Reporting Manager
Anders Hove
Security
OnKure Therapeutics, Inc. Common Stock, $0.0001 Par Value
Symbol
RPHM
Shares outstanding
41,305,653 shares
Disclosed Ownership
3,924,037 shares
Ownership
9.5%
Form type
SCHEDULE 13G
Filing time
01 Apr 2026, 11:17:33 UTC
Date of event
27 Mar 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ACORN BIOVENTURES, L.P. disclosed 9.5% ownership in OnKure Therapeutics, Inc. Common Stock, $0.0001 Par Value (RPHM) on 27 Mar 2026."

Quick Takeaways

  • ACORN BIOVENTURES, L.P. filed SCHEDULE 13G for OnKure Therapeutics, Inc. Common Stock, $0.0001 Par Value (RPHM).
  • Disclosed ownership: 9.5%.
  • Date of event: 27 Mar 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 01 Apr 2026, 11:17.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ACORN BIOVENTURES, L.P. 4.5% 1,854,525 0 1,854,525 Anders Hove Manager of General Partner
ACORN CAPITAL ADVISORS GP, LLC 4.5% 1,854,525 0 1,854,525 Anders Hove Manager
ACORN BIOVENTURES 2, L.P. 5% 2,069,512 0 2,069,512 Anders Hove Manager of General Partner
Acorn Capital Advisors GP 2, LLC 5% 2,069,512 0 2,069,512 Anders Hove Manager
Anders Hove 9.5% 3,924,037 0 3,924,037 Anders Hove Individually

Sponsored